Evidence map›Paper›PMID 33032673›Full record

ReviewThe British journal of nutrition2021

Mechanisms linking the human gut microbiome to prophylactic and treatment strategies for COVID-19.

Gemma E Walton, Glenn R Gibson, Kirsty A Hunter

Abstract readReview
In one paragraph

Review in The British journal of nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Antioxidant/anti-inflammatory effect of MgReviews in medical virology · 2022
    Review
  13. Review
  14. Review
  15. Review
  16. Awareness, Knowledge, and Interest about Prebiotics-A Study among Romanian Consumers.International journal of environmental research and public health · 2022
    Article
  17. Clinical features and mechanistic insights into drug repurposing for combating COVID-19.The international journal of biochemistry & cell biology · 2022
    Review
  18. Review
  19. Post-acute Sequelae in COVID-19 Survivors: an Overview.SN comprehensive clinical medicine · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gemma E WaltonFood Microbial Sciences Unit, Department of Food and Nutritional Sciences, University of Reading, ReadingRG6 6AP, UK.
Glenn R GibsonFood Microbial Sciences Unit, Department of Food and Nutritional Sciences, University of Reading, ReadingRG6 6AP, UK.
Kirsty A HunterExercise and Health Research Group, Department of Sport Science, Sport, Health and Performance Enhancement (SHAPE) Research Centre, Nottingham Trent University, NottinghamNG11 8NS, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent COVID-19 pandemic has altered the face of biology, social interaction and public health worldwide. It has had a destructive effect upon millions of people and is approaching a devastating one million fatalities. Emerging evidence has suggested a link between the infection and gut microbiome status. This is one of the several factors that may contribute towards severity of infection. Given the fact that the gut is heavily linked to immunity, inflammatory status and the ability to challenge pathogens, it is worthwhile to consider dietary intervention of the gut microbiota as means of potentially challenging the viral outcome. In this context, probiotics and prebiotics have been used to mitigate similar respiratory infections. Here, we summarise links between the gut microbiome and COVID-19 infection, as well as propose mechanisms whereby probiotic and prebiotic interventions may act.

Indexed as

Gastrointestinal MicrobiomeCOVID-19HumansPrebioticsProbioticsSARS-CoV-2SynbioticsPrebioticsCoronavirusCOVID-19Gut microbiomePrebioticsProbiotics

Identifiers

PMID33032673
PMCPMC7684010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.